Outcome of Board Meeting
Fredun Pharmaceuticals Ltd has informed BSE about Outcome of Board Meeting held on January 18, 2017.19-01-2017
19-01-2017
Board Meeting on Jan 18, 2017
Fredun Pharmaceuticals Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on January 18, 2017, for the purpose of-1. To consider obtaining on lease a property for storage purposes for a period of 12 months.2. To consider the matter of obtaining a Loan from Fredun Healthcare Private Limited.3. To consider the matter of obtaining a Loan from one or more NBFC(s) if required.11-01-2017
Limited Review Report for September 30, 2016
Fredun Pharmaceuticals Ltd has informed BSE about : 1. Standalone Limited Review for the period ended September 30, 201610-11-2016
Standalone Financial Results for September 30, 2016
Fredun Pharmaceuticals Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 201609-11-2016
Outcome of Board Meeting
Fredun Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 09, 2016, has transacted the following:- Availing Credit Facility of One Crore:The Board of Directors after consideration decided to avail a Credit Facility as negotiated which may be modified if required for rupees One Crore from Induslnd Bank i.e. Bankers to the Company for a maximum period of 90 days.09-11-2016
Board Meeting on Nov 09, 2016
Fredun Pharmaceuticals Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on November 09, 2016, for the purpose of;1. To consider approve and take on records the un-audited quarterly and six-monthly financial results as on September 30, 2016; and2. To consider availing credit facility of Rs. 1,00,00,000 (One Crore) from Induslnd Bank (Bankers to the Company).02-11-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Fredun Pharmaceuticals Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.22-10-2016
Shareholding for the Period Ended September 30, 2016
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here18-10-2016
Outcome of Board Meeting
Fredun Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 07, 2016, as under;- Chairman;Mr. Nariman Medhora occupied the Chair as the Chairman of the Meeting- Leave of Absence;The Board made note of the Directors present.- Minutes of previous Board Meeting;...07-10-2016
Board Meeting on Oct 07, 2016
Fredun Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 07, 2016, to consider obtaining on lease premises for office use.29-09-2016